TMC NEWS

TMCNET eNEWSLETTER SIGNUP

Pebble Labs Builds Science Team with Four Research Hires

Pebble
Labs Inc., the biotechnology company developing biologically
engineered solutions to eliminate the transmission of mosquito-carried
diseases including Zika and Dengue, today announced the hiring of four
Research Scientists to join Dr. Richard Sayre, Chief Scientific Officer
and co-founder of Pebble Labs.

"Pebble Labs is building and investing in a biotechnology solution that
has the potential to stop the global spread of Zika, Dengue, Yellow
Fever and host of other tragic human, plant and aquaculture diseases,
and to do so without harming the environment," said Michael Harrison,
Pebble Labs CEO. "Dr. Sayre and his growing team of best-in-class
scientists are pioneering technology that can positively impact the
lives of millions of people for generations to come."

"I'm proud to lead such a high caliber team that is truly breaking new
ground in the fight against vector-borne diseases," said Dr. Sayre. In
addition to his role at Pebble Labs, Dr. Sayre is one of the top
research scientists at Los Alamos National Laboratory and the New Mexico
Consortium, and author or more than 130 biotechnology papers and patents.

Pebble Labs said it hired four full-time Research Scientists:

Dr. Konstantinos Lymperopoulos holds a PhD in biochemistry from the
University of Oxford with a background in chemistry, virology and
biophysics. He spent more than 10 years at the BioQuant Institute and
the University of Oxford as a research scientist. His expertise lies
in bio-molecular interactions, novel technology platforms and gene
therapy and he has authored more than 11 publications.

Dr. Pedro Miguel Melo da Costa Nunes holds a Ph in biology from
Instituto Superior de Agronomia, Technical University of Lisbon,
Portugal. He was most recently a Research Scientist at the Donald
Danforth Plant Science Center in St. Louis, Missouri. He has expertise
in RNA. He has authored more than 17 publications, with two in
preparation.

Dr. Tatiana Vinogradova-Shah has a PhD in Cell Biology from the
Institute of Experimental Cardiology in Moscow, Russia, and has
expertise in cell and development biology. Previously, she held
positions at the Wadsworth Center and Vanderbilt University Medical
Center. She is author of more than 11 publications.

Dr. Guohau (Karen) Yin has a PhD in Molecular Plant Pathology from the
State Key Laboratory of Crop Biology in Shandong, China. She
previously held positions as a research scientist at the University of
Arizona, Rutgers University, University of Arkansas and Tel Aviv
University. Dr. Yin has expertise in molecular biology and
biotechnology such as next-generation sequencing and re-sequencing.
She is the author of 45 publications, with another 11 under review or
in preparation.

The growing Pebble Labs scientific research team is based at the New
Mexico Consortium working out of the Los Alamos National Laboratory
under the direction of Dr. Sayre.

Pebble Labs' Approach

Pebble Labs' mission is disease control and food-security by combating
mosquito-borne and other viral- and fungal-based diseases in crops and
aquaculture which, if left untreated, result in untold human tragedy and
annual global monetary losses of more than $150 billion. The technology
prevents the transmission of viral and fungal disease and does not have
any negative human, eco-system or environmental impact.

The approach is a scientific breakthrough leveraging technology and
biology that has been developed over the last 10 years in the US's top
national labs and universities. The solution naturally hinders an
organism's ability to replicate targeted viruses via proprietary and
patent-pending food-source bacteria designed to block virus replication.
This is completely safe for all other organisms-including the targeted
organism. The bacteria can be applied cost-effectively in affected areas
across the globe.

Pebble Labs uses an innovative "distributed" model for scientific
research, collaborating with world class experts in academia and the
private sector. Pebble Labs retains control over operations and
ownership for all core IP. The company coordinates research from one
central location (The New Mexico Consortium) and uses world class
facilities at Colorado State University, the New Mexico State
University, the National Center for Genome Resources and others for
research. Research is supplemented with the oversight of a Scientific
Advisory Board.

About Pebble Labs

Founded at the New Mexico Consortium, Pebble Labs Inc. is a
biotechnology company developing biologically engineered bacteria to
eliminate the transmission of mosquito-carried viruses including Zika
and Dengue and other viral- and fungal-based diseases in crops and
aquaculture. www.pebblelabs.com